About   Help   FAQ
Phenotypes associated with this allele
Allele Symbol
Allele Name
Allele ID
Fgf14Tg(tetO-MAPT*P301L)4510Kha
transgene insertion 4510, Karen Hsiao Ashe
MGI:4819866
Summary 4 genotypes
Jump to Allelic Composition Genetic Background Genotype ID
cx1
Tg(Camk2a-tTA)1Mmay/?
Fgf14Tg(tetO-MAPT*P301L)4510Kha/?
involves: 129S6/SvEvTac * FVB/N MGI:4819951
cx2
Tg(Camk2a-tTA)1Mmay/0
Fgf14Tg(tetO-MAPT*P301L)4510Kha/Fgf14+
involves: 129S6/SvEvTac * FVB/N MGI:5558945
cx3
Tg(Camk2a-tTA)1Mmay/0
Fgf14Tg(tetO-MAPT*P301L)4510Kha/Fgf14+
involves: 129/Sv * C57BL/6 * CBA * FVB/N MGI:5438795
cx4
Tg(Camk2a-tTA)1Mmay/0
Fgf14Tg(tetO-MAPT*P301L)4510Kha/Fgf14+
involves: FVB/N MGI:5511058


Genotype
MGI:4819951
cx1
Allelic
Composition
Tg(Camk2a-tTA)1Mmay/?
Fgf14Tg(tetO-MAPT*P301L)4510Kha/?
Genetic
Background
involves: 129S6/SvEvTac * FVB/N
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Fgf14Tg(tetO-MAPT*P301L)4510Kha mutation (2 available); any Fgf14 mutation (40 available)
Tg(Camk2a-tTA)1Mmay mutation (8 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
nervous system
• a significant loss in brain weight by 5.5 months
• when treated with doxycycline during 5.5 to 10 months, the loss of brain weight was significantly protected
• significant decrease in total numbers of CA1 hippocampal neurons
• CA1 neuron estimates were stabilized after brief (6- to 8-week) doxycycline treatment
• gross atrophy of the forebrain was evident in a 10-month-old mouse
• develop argyrophilic tangle-like inclusions in the cortex by 4 months and in the hippocampal formation by 5.5 months
• when treated with doxycycline at 2.5 month, the tau pathology ceased to progress
• the neuronal inclusions composed of a mass of straight tau filaments
• when treated with doxycycline at 2.5 month, the tau pathology ceased to progress
• approximately 23% of CA1 pyramidal cells remaining at 8.5 months
• CA1 neuron estimates were stabilized after brief (6- to 8-week) doxycycline treatment

behavior/neurological
• he retention of spatial memory examined by the Morris water maze were impaired as the mice aged
• deficit in spatial navigation was also seen in younger mice
• the performance improved when treated with doxycycline at 2.5 month-old or at 5.5 month-old

Mouse Models of Human Disease
DO ID OMIM ID(s) Ref(s)
Alzheimer's disease DOID:10652 J:99626




Genotype
MGI:5558945
cx2
Allelic
Composition
Tg(Camk2a-tTA)1Mmay/0
Fgf14Tg(tetO-MAPT*P301L)4510Kha/Fgf14+
Genetic
Background
involves: 129S6/SvEvTac * FVB/N
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Fgf14Tg(tetO-MAPT*P301L)4510Kha mutation (2 available); any Fgf14 mutation (40 available)
Tg(Camk2a-tTA)1Mmay mutation (8 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
behavior/neurological
• progressive decrease in percent of time spent freezing in response to unconditioned stimulus beginning at 2 months of age
• progressive decrease in percent of time spent freezing in response to conditioned stimulus beginning at 6 months of age
• amount of time spent in open arms of elevated plus maze is increased relative to nontransgenic mice at 6 and 10 months of age, but not 2 months
• higher ratio of time spent in open not closed arms relative to nontransgenic mice at 10 months of age, but not 2 or 6 months
• exploration of light chamber is increased relative to nontransgenic mice at 6 months of age, but not 2 or 10 months
• higher ratio of time spent in light not dark relative to nontransgenic miceat 10 months of age, but not 2 or 6 months
• decreased tendency to explore the center of the open field relative to nontransgenic mice
• mice exhibit progressive hyperactivity in open field analysis and elevated plus maze
• total distance travelled in open field assay is increased relative to nontransgenic mice at 6 and 10 months of age, but not 2 months
• average speed is increased relative to nontransgenic mice at 6 and 10 months of age, but not 2 months
• total time spent mobile is increased relative to nontransgenic mice at 6 and 10 months of age, but not 2 months

nervous system
• neurofibrilliary tangles are observed by immunostaining in the CA1 region of the hippocampus beginning at 6 months of age and progressing to an extensive pathology by 11 months of age
• neurofibrilliary tangles are observed by immunostaining in the amygdala beginning at 2 months of age and progressing to an extensive pathology by 10 months of age
• tau burden increases with age in the amygdala and CA1 region of the hippocampus

Mouse Models of Human Disease
DO ID OMIM ID(s) Ref(s)
frontotemporal dementia DOID:9255 OMIM:600274
J:207366




Genotype
MGI:5438795
cx3
Allelic
Composition
Tg(Camk2a-tTA)1Mmay/0
Fgf14Tg(tetO-MAPT*P301L)4510Kha/Fgf14+
Genetic
Background
involves: 129/Sv * C57BL/6 * CBA * FVB/N
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Fgf14Tg(tetO-MAPT*P301L)4510Kha mutation (2 available); any Fgf14 mutation (40 available)
Tg(Camk2a-tTA)1Mmay mutation (8 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
nervous system
• progressive atrophy of dentate granule cells
• progressive atrophy of hippocampal pyramidal neurons




Genotype
MGI:5511058
cx4
Allelic
Composition
Tg(Camk2a-tTA)1Mmay/0
Fgf14Tg(tetO-MAPT*P301L)4510Kha/Fgf14+
Genetic
Background
involves: FVB/N
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Fgf14Tg(tetO-MAPT*P301L)4510Kha mutation (2 available); any Fgf14 mutation (40 available)
Tg(Camk2a-tTA)1Mmay mutation (8 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
behavior/neurological
• reduction in exploration in open-field tests
• mutants first exhibit impaired spatial reference memory at 2.5 months of age, showing a slightly reduced search bias for the target quadrant than controls in the Morris water maze
• spatial memory retention becomes more impaired with age, especially after 4 months of age, with the mean probe performance being equal to random swimming, indicating little or no retention of spatial memory
• mutants exhibit cognitive impairments in the acquisition phases of the Morris water maze, showing a longer mean distance to locate the hidden platform
• clasping and limb retraction when lifted by the tail
• develop dystonic posture with tail rigor at 9.5 months of age
• mutants exhibit longer latencies to traverse a beam
• mutants develop an age-dependent increase in the time taken to start swimming, however they are able to achieve comparable mean swim speeds during probe trials
• from about 9.5 months of age, the most severely affected mutants develop hunched posture with hindlimb dysfunction and tail rigor
• from about 9.5 months of age, the most severely affected mutants exhibit decreased ambulation

growth/size/body
• from about 9.5 months of age, the most severely affected mutants exhibit decreased body weight

nervous system
• 4-7% reduction in brain weight at 4 months of age
• atrophy of the forebrain is seen by 5 months of age
• age-dependent progression of tau processing that results in pathophysiological deposition of tau as mature tangles in the brain
• mutants exhibit age-dependent progression of neurofibrillary tangle formation, with tangles first appearing in the neocortex and then progressing into the hippocampus and limbic structures with increasing age
• neurofibrillary tangles develop in the hippocampus in a distinct pattern; mature tangles occur initially in CA1 pyramidal neurons, spread to CA2, and by 8.5 months of age include pyramidal neurons in CA2 and granular neurons of the dentate gyrus
• abnormal conformations of tau are present in the hippocampus and neocortex of 2.5-month old mutants
• reactive astrocytes in forebrains of 10 month old mutants
• atrophy of the dorsal corticospinal tracts accompanied by loss of neurofilament
• degeneration in the hippocampus and neocortex is seen in 10 month old mutants
• massive neuronal loss, most apparent in the CA1 region of the hippocampus
• spinal cords appear thinner, however, no decrease in motor neuron density is seen

muscle
• develop dystonic posture with tail rigor at 9.5 months of age

Mouse Models of Human Disease
DO ID OMIM ID(s) Ref(s)
Alzheimer's disease DOID:10652 J:102973
frontotemporal dementia DOID:9255 OMIM:600274
J:102973





Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
04/30/2024
MGI 6.23
The Jackson Laboratory